SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-015537
Filing Date
2022-08-08
Accepted
2022-08-08 16:14:06
Documents
14
Period of Report
2022-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K me-20220808.htm   iXBRL 8-K 66141
2 EX-99.1 me-ex99_1.htm EX-99.1 614174
  Complete submission text file 0000950170-22-015537.txt   859342

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220808.xsd EX-101.SCH 3354
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220808_pre.xml EX-101.PRE 14331
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220808_lab.xml EX-101.LAB 22458
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20220808_def.xml EX-101.DEF 14171
8 EXTRACTED XBRL INSTANCE DOCUMENT me-20220808_htm.xml XML 4542
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 221144533
SIC: 2834 Pharmaceutical Preparations